Cytolytic virus activation therapy and treatment monitoring for Epstein-Barr virus associated nasopharyngeal carcinoma in a mouse tumor model. [electronic resource]
Producer: 20180531Description: 2207-2216 p. digitalISSN:- 1096-9071
- Animals
- Antiviral Agents -- blood
- Carcinoma -- drug therapy
- DNA, Viral -- genetics
- Deoxycytidine -- analogs & derivatives
- Disease Models, Animal
- Epstein-Barr Virus Infections -- complications
- Ganciclovir -- administration & dosage
- Herpesvirus 4, Human -- drug effects
- Humans
- Mice
- Mice, Nude
- Nasopharyngeal Carcinoma
- Nasopharyngeal Neoplasms -- drug therapy
- Treatment Outcome
- Tumor Cells, Cultured
- Valproic Acid -- pharmacology
- Viral Load -- methods
- Virus Activation
- Gemcitabine
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.